Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database
Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2
PTAB institution rates for pharmaceutical patents ran at approximately 60-65% historically, and claim cancellation rates at instituted trials ran above 70%, though these figures have moderated somewhat under more recent USPTO director guidance
With insurance + savings card: as low as $25
,aspect=ignore)
US$ 26.70
US$ 26.80
US$ 26.93
US$ 20.76
